Edap Tms Sa Quick Ratio (EDAP) starting from the second quarter 2026 to second quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Edap Tms Sa  (NASDAQ: EDAP)

Edap Tms Sa's Quick Ratio

EDAP's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Edap Tms Sa's Cash & cash equivalent grew by 24.59 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Edap Tms Sa's Quick Ratio to 0.58, Quick Ratio remained below Edap Tms Sa average.

Within Medical Equipment & Supplies industry 140 other companies have achieved higher Quick Ratio than Edap Tms Sa in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 1566 to 2479.

Explain Quick Ratio?
How much Cash & cash equivalents EDAP´s has?
What are EDAP´s Current Liabilities?




EDAP Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Mar 31 2025)
Q2
(Dec 31 2024)
Q1
Y / Y Current Liabilities Change -31.75 % -23.82 % -53.65 % - 80.26 %
Y / Y Cash & cash equivalent Change -30.5 % -48.26 % -38.8 % - -36.34 %
Quick Ratio MRQ 0.58 0.54 1.04 - 0.57
EDAP's Total Ranking # 2479 # 1566 # 2364 # #
Seq. Current Liabilities Change 14.23 % 64.37 % - - 27.49 %
Seq. Cash & cash equivalent Change 24.59 % -15.46 % - - -7.25 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 141
Healthcare Sector # 721
Overall Market # 2479


Quick Ratio Statistics
High Average Low
3.11 1.3 0.38
(Dec 31 2022)   (Dec 31 2011)




Financial Statements
Edap Tms Sa's Current Liabilities $ 37 Millions Visit EDAP's Balance sheet
Edap Tms Sa's Cash & cash equivalent $ 22 Millions Visit EDAP's Balance sheet
Source of EDAP's Sales Visit EDAP's Sales by Geography


Cumulative Edap Tms Sa's Quick Ratio

EDAP's Quick Ratio for the trailling 12 Months

EDAP Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Mar 31 2025)
12 Months
(Dec 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth -50.98 % -32.56 % -20.33 % 3.41 % 47.57 %
Y / Y Cash & cash equivalent TTM Growth -54.83 % -53.85 % -48.32 % -45.49 % -32.61 %
Quick Ratio TTM 0.67 0.65 0.73 0.71 0.72
Total Ranking TTM # # # # #
Seq. Current Liabilities TTM Growth -16.19 % -8.7 % -16.38 % -23.39 % 15.31 %
Seq. Cash & cash equivalent TTM Growth -13.75 % -19 % -13.25 % -25.46 % -11.88 %


On the trailing twelve months basis Current Liabilities decreased faster than Edap Tms Sa's average Cash & cash equivalent, this led to increase in in Edap Tms Sa's Quick Ratio to 0.67, Quick Ratio remained below EDAP average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 140 other companies have achieved higher Quick Ratio than Edap Tms Sa. While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 2034.

Explain Quick Ratio?
How much Cash & cash equivalents EDAP´s has?
What are EDAP´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 141
Healthcare Sector # 721
Within the Market # 2479


trailing twelve months Quick Ratio Statistics
High Average Low
3.11 1.3 0.38
(Dec 31 2022)   (Dec 31 2011)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Seastar Medical Holding Corp  1.60 $ 6.959  Millions$ 4.353  Millions
Tela Bio Inc   1.59 $ 30.424  Millions$ 19.080  Millions
Conexeu Sciences Inc   1.55 $ 1.971  Millions$ 1.272  Millions
Inogen Inc   1.49 $ 105.539  Millions$ 70.864  Millions
Dariohealth Corp   1.49 $ 14.254  Millions$ 9.578  Millions
Myomo Inc   1.45 $ 15.686  Millions$ 10.805  Millions
Envoy Medical Inc   1.43 $ 19.679  Millions$ 13.807  Millions
Nephros Inc   1.40 $ 4.697  Millions$ 3.344  Millions
Envista Holdings Corporation  1.39 $ 1,125.600  Millions$ 807.300  Millions
Medtronic Plc  1.36 $ 16,068.000  Millions$ 11,799.000  Millions
Sanara Medtech Inc   1.31 $ 16.421  Millions$ 12.494  Millions
Globus Medical Inc   1.24 $ 595.142  Millions$ 479.347  Millions
Lucid Diagnostics Inc   1.21 $ 33.404  Millions$ 27.516  Millions
Sintx Technologies Inc   1.21 $ 3.590  Millions$ 2.977  Millions
Vaso Corporation  1.17 $ 38.291  Millions$ 32.863  Millions
Koru Medical Systems Inc   1.15 $ 8.288  Millions$ 7.180  Millions
Establishment Labs Holdings Inc   1.10 $ 71.157  Millions$ 64.558  Millions
Treace Medical Concepts Inc   1.10 $ 45.619  Millions$ 41.496  Millions
Resmed Inc   1.05 $ 1,469.234  Millions$ 1,395.110  Millions
Adagio Medical Holdings inc   1.02 $ 7.740  Millions$ 7.562  Millions
Plus Therapeutics Inc   1.00 $ 8.587  Millions$ 8.567  Millions
Pavmed Inc   1.00 $ 4.070  Millions$ 4.088  Millions
Sonoma Pharmaceuticals Inc   0.98 $ 5.338  Millions$ 5.447  Millions
Nuwellis Inc   0.98 $ 3.922  Millions$ 4.008  Millions
Electrocore Inc   0.97 $ 11.543  Millions$ 11.933  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  0.96 $ 10.924  Millions$ 11.366  Millions
Medline Inc   0.96 $ 2,677.000  Millions$ 2,803.000  Millions
Neuronetics Inc   0.88 $ 24.947  Millions$ 28.309  Millions
Orthopediatrics Corp  0.87 $ 45.879  Millions$ 52.852  Millions
Haemonetics Corporation  0.85 $ 223.384  Millions$ 263.235  Millions

Date modified: 2026-09-08T17:30:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.